super responders to tirzepatide Decoding the hallmarks of GLP-1RA weight-loss Researchers move closer to matching

Some compounding pharmacies submit their products to independent laboratories for identity, potency, sterility, and endotoxin testing

It is most associated with SGLT2 inhibitors (a different class of diabetes drug) but has been reported with GLP-1 medications in the context of very low carbohydrate intake, particularly during illness, fasting, or periods of very low food intake

With telehealth, you receive: Telehealth makes high-quality medical weight loss more accessible and affordable for everyone

The SURMOUNT-1 clinical trial showed that participants on just 5 mg lost an average of 15% of their body weight over 72 weeks